Quantitative imaging biomarker for lung cancer

US12548166B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12548166-B2
Application numberUS-202318176911-A
CountryUS
Kind codeB2
Filing dateMar 1, 2023
Priority dateSep 2, 2020
Publication dateFeb 10, 2026
Grant dateFeb 10, 2026

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

In one or more implementations, systems, methods and computer implemented processes are provided that are directed to a method of treating a subject with a lung tumor, the method comprising: obtaining computed tomography (CT) image slices of the subject, wherein the CT image slices comprise images of the lung tumor. In a further implementation, the systems, methods and computer implemented processes are directed to identifying a first CT image slice where the lung tumor has a largest diameter among the CT image slices; and determining intensity-skewness of the lung tumor on the first CT image slice. In a further implementation, the systems, methods and computer implemented processes are directed to treating the subject with surgery, chemotherapy and/or radiotherapy, if the intensity-skewness is no greater than −1.5.

First claim

Opening claim text (preview).

The invention claimed is: 1 . A method of treating a subject with a lung tumor, the method comprising: (a) obtaining computed tomography (CT) image slices of the subject, wherein the CT image slices comprise images of the lung tumor; (b) identifying a first CT image slice where the lung tumor has a largest diameter among the CT image slices; (c) determining intensity-skewness of the lung tumor on the first CT image slice; (d) classifying the subject to one of disease-free-survival (DFS)-associated histologic subgroup based on a comparison of the intensity-skewness to a threshold value; and (e) treating the subject with at least one of surgery, chemotherapy and/or radiotherapy, where the intensity-skewness is no greater than the threshold value. 2 . The method of claim 1 , wherein the intensity-skewness is: Intensity_Skewness = 1 N ⁢ ∑ i = 1 N ⁢ ( X ⁡ ( i ) - X ¯ ) 3 ( 1 N ⁢ ∑ i = 1 N ⁢ ( X ⁡ ( i ) - X ¯ ) 2 ) 3 wherein the first CT image slice N pixels: 1, . . . ith, . . . N, X(i) being an intensity of the ith pixel within the first CT image slice, X being a mean intensity of all pixels within the first CT image slice. 3 . The method of claim 1 , wherein the threshold value is accessed from a pre-trained machine learning model configured to output a value that corresponds to the demarcation between a first disease-free-survival (DFS)-associated histologic subgroup and a second disease-free-survival (DFS)-associated histologic subgroup-, wherein the pre-trained model is trained using a training set of CT images. 4 . A method for treating a subject with a lung tumor, the method comprising: (a) obtaining computed tomography (CT) image slices of the subject, wherein the CT image slices comprise images of the lung tumor; (b) identifying a first CT image slice where the lung tumor has a largest diameter among the CT image slices; (c) determining intensity-skewness of the lung tumor on the first CT image slice; (d) determining that the lung tumor is a mid/poor disease-free-survival (DFS)-associated histologic subgroup, if the intensity-skewness is no greater than −1.5; and (e) treating the subject with at least one of surgery, chemotherapy and/or radiotherapy. 5 . The method of claim 4 , wherein intensity-skewness is: Intensity_Skewness = 1 N ⁢ ∑ i = 1 N ⁢ ( X ⁡ ( i ) - X ¯ ) 3 ( 1 N ⁢ ∑ i = 1 N ⁢ ( X ⁡ ( i ) - X ¯ ) 2 ) 3 wherein the first CT image slice has N pixels: 1, . . . ith, . . . N, X(i) being an intensity of the ith pixel within the first CT image slice, X being a mean intensity of all pixels within the first CT image slice. 6 . The method of claim 1 , wherein the lung tumor is lung adenocarcinoma. 7 . The method of claim 6 , wherein the lung adenocarcinoma is invasive adenocarcinoma. 8 . The method of claim 7 , wherein the

Assignees

Inventors

Classifications

  • Lung nodule · CPC title

  • Computed x-ray tomography [CT] · CPC title

  • Biomedical image inspection · CPC title

  • for handling medical images, e.g. DICOM, HL7 or PACS · CPC title

  • for patient-specific data, e.g. for electronic patient records · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12548166B2 cover?
In one or more implementations, systems, methods and computer implemented processes are provided that are directed to a method of treating a subject with a lung tumor, the method comprising: obtaining computed tomography (CT) image slices of the subject, wherein the CT image slices comprise images of the lung tumor. In a further implementation, the systems, methods and computer implemented proc…
Who is the assignee on this patent?
Univ Columbia
What technology area does this patent fall under?
Primary CPC classification G06T7/136. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Feb 10 2026 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 9 related publications on this page (citations in our corpus or others sharing the same primary CPC).